Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Frontiers in Oncology
|
June 27, 2024
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience
Evangelia Vlachou, Burles Avner Johnson, David McConkey, et al.
European Urology Open Science
|
February 23, 2023
Enfortumab Vedotin-related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature
Evangelia Vlachou, Andres Matoso, David McConkey, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase
Fabio P S Santos, Hagop Kantarjian, David McConkey, et al.
The Journal of Urology
|
April 18, 2007
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer
Liana Adam, Peter C Black, Wassim Kassouf, et al.
Clinical Genitourinary Cancer
|
December 28, 2020
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
Jean Hoffman-Censits, Woonyoung Choi, Trinity J Bivalacqua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy
Liana Adam, Meng Zhong, Woonyoung Choi, et al.
Cancer Research
|
February 20, 2003
Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells
Xinqiao Zhang, Asha S Multani, Jain-Hua Zhou, et al.
The Journal of Urology
|
January 9, 2018
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
Ross S Liao, Mohit Gupta, Zeyad R Schwen, et al.
European Urology
|
November 5, 2021
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer
Woonyoung Choi, Kara Lombardo, Sunil Patel, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Frontiers in Oncology
|
June 27, 2024
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience
Evangelia Vlachou, Burles Avner Johnson, David McConkey, et al.
European Urology Open Science
|
February 23, 2023
Enfortumab Vedotin-related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature
Evangelia Vlachou, Andres Matoso, David McConkey, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase
Fabio P S Santos, Hagop Kantarjian, David McConkey, et al.
The Journal of Urology
|
April 18, 2007
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer
Liana Adam, Peter C Black, Wassim Kassouf, et al.
Clinical Genitourinary Cancer
|
December 28, 2020
Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience
Jean Hoffman-Censits, Woonyoung Choi, Trinity J Bivalacqua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy
Liana Adam, Meng Zhong, Woonyoung Choi, et al.
Cancer Research
|
February 20, 2003
Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells
Xinqiao Zhang, Asha S Multani, Jain-Hua Zhou, et al.
The Journal of Urology
|
January 9, 2018
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma
Ross S Liao, Mohit Gupta, Zeyad R Schwen, et al.
European Urology
|
November 5, 2021
A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer
Woonyoung Choi, Kara Lombardo, Sunil Patel, et al.
Page
of 8